Few Julius W, Vachon Ginny, Pintas Stephanie, Smith Jesse R
University of Chicago Pritzker School of Medicine, Chicago, IL.
Principal Medvantage Writing, LLC.
Aesthet Surg J Open Forum. 2019 Oct 19;2(1):ojz029. doi: 10.1093/asjof/ojz029. eCollection 2020 Jan.
Absorbable suspension sutures are the only nonsurgical modality approved for tissue repositioning.
To quantitate patient perceptions of treatment at 24 months and determine the impact of age and prior surgical procedures on perceptions of efficacy, treatment longevity, and overall satisfaction. In addition, the authors sought to describe the impact of treatment with absorbable suspension sutures on the likelihood a patient will undergo future surgical procedures.
The first 100 treated patients who underwent treatment with absorbable suspension sutures, by the senior author, were critically evaluated. Subjects completed surveys 24 months following initial treatment.
Of the initial 100 patients, complete records were available for 80 patients (age 39-86). Eighteen (22.5%) received a second treatment with absorbable suspension sutures and average time to second treatment was 23.4 months (range 13-37 months). Overall satisfaction was affected by age, 100% of patients ≤ 50 vs. 60% of patients > 50 ( = 0.026). Prior surgery appeared to be a factor in patient perception of efficacy: 82.6% of patients with no prior surgery indicated that absorbable suspension sutures were effective vs. 45.5% of patients with a prior surgical procedure ( = 0.0286). Just under one third of pretreatment surgical patients underwent surgery following treatment while 25% of surgery naïve patients went on to have surgery. Importantly, satisfaction with the initial procedure does not preclude later surgery.
Treatment with absorbable suspension sutures is associated with high satisfaction through 24 months and does deter patients from surgery. The combination of lift and volumization results in 4-dimensional rejuvenation that includes rejuvenation of dynamic expression.
可吸收悬吊缝线是唯一被批准用于组织复位的非手术方式。
量化患者在24个月时对治疗的感知，并确定年龄和既往手术对疗效、治疗持久性及总体满意度感知的影响。此外，作者试图描述可吸收悬吊缝线治疗对患者未来接受手术可能性的影响。
对由资深作者使用可吸收悬吊缝线治疗的首批100例患者进行严格评估。受试者在初始治疗24个月后完成问卷调查。
最初的100例患者中，80例（年龄39 - 86岁）有完整记录。18例（22.5%）接受了可吸收悬吊缝线的二次治疗，二次治疗的平均时间为23.4个月（范围13 - 37个月）。总体满意度受年龄影响，≤50岁的患者中有100%满意，而>50岁的患者中这一比例为60%（P = 0.026）。既往手术似乎是影响患者疗效感知的一个因素：无既往手术的患者中有82.6%表示可吸收悬吊缝线有效，而有既往手术的患者中这一比例为45.5%（P = 0.0286）。治疗前接受过手术的患者中略少于三分之一在治疗后接受了手术，而未接受过手术的患者中有25%随后接受了手术。重要的是，对初始治疗的满意度并不排除后续手术。
可吸收悬吊缝线治疗在24个月内满意度较高，且确实能阻止患者进行手术。提升和容积增加相结合可实现四维年轻化，包括动态表情的年轻化。
